Cognizant to apply generative AI to enhance drug discovery for pharmaceutical clients with NVIDIA BioNeMo

Cognizant Benin Burkina Faso Burundi Cameroon Chad Comoros Cote d'Ivoire Djibouti Ethiopia Gabon Gambia Ghana Guinea Equatorial Guinea Kenya Liberia Madagascar Mali Namibia Niger Nigeria Central African Republic Congo, The Democratic Republic of the Congo, The Republic of the Senegal Sierra Leone South Africa Sudan Tanzania Tonga Uganda Zambia Zimbabwe Algeria Angola Botswana Cape Verde Egypt Eritrea Guinea-Bissau Lesotho Libya Malawi Mauritania Mauritius Morocco Mozambique Rwanda Sao Tome and Principe Seychelles South Sudan Swaziland Togo Tunisia New Jersey

or @cognizant.

For more information, contact:

U.S.

Name Ben Gorelick

Email 
[e-mail] 

Europe / APAC

Name Christina Schneider

Email
[e-mail] 

India

Name Rashmi Vasisht

Email
[e-mail] 

Logo - https://mma.prnewswire.com/media/1794711/Cognizant_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/cognizant-to-apply-generative-ai-to-enhance-drug-discovery-for-pharmaceutical-clients-with-nvidia-bionemo-302092233.html